While we are attuned to the issues faced by society at large, we endeavor to provide flexible and sensitive care that is optimized to patients as individuals, going beyond existing pharmaceutical, home healthcare and ICT frameworks. Further, we are prioritizing startup co-creation and diversity, particularly in the fields of rare and intractable diseases, to evolve conventional approaches. Every member of Teijin Pharma is an evolutionary leader, and our passion for breaking new ground is at the heart of every move we make.
Masaki Taneda
President, Teijin Pharma Limited
Our goal is to become a company, striving to resolve the challenges faced by patients, families, and communities in need of greater support. Right now, our focus is on reinforcing Teijin Pharma’s globally active drug development platform. As well as maintaining a network of administrative and sales locations established in communities across Japan, we are advancing new platforms including customer centers, home visit nursing stations and our VitalLink patient information sharing system.
While we are attuned to the issues faced by society at large, we endeavor to provide flexible and sensitive care that is optimized to patients as individuals, going beyond existing pharmaceutical, home healthcare and ICT frameworks. Further, we are prioritizing startup co-creation and diversity, particularly in the fields of rare and intractable diseases, to evolve conventional approaches. Every member of Teijin Pharma is an evolutionary leader, and our passion for breaking new ground is at the heart of every move we make.
Masaki Taneda
President, Teijin Pharma Limited
